4

OWNERSHIP DOCUMENT

Company: BioXcel Therapeutics, Inc.
Filed: February 16, 2021
Period of Report: July 24, 2020
Accession Number: 0001104659-21-024409

View Document ↗ View on SEC.gov ↗